Ingrid Kromann

Prevention of <i>M. tuberculosis</i> Infection with H4:IC31 Vaccine or BCG Revaccination

Elisa Nemes, Hennie Geldenhuys, Virginie Rozot et al. · New England Journal of Medicine · 2018 · 667 citations · Full text

Public Health, Infectious Diseases, Pediatrics +17

Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin

D. J. Lewis, Zhiming Huo, Susan W. Barnett et al. · PLoS ONE · 2009 · 302 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human

Jaap T. van Dissel, Simone A. Joosten, Søren T. Hoff et al. · Vaccine · 2014 · 243 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial

Sonya Abraham, Helene Bæk Juel, Peter Fibiger Bang et al. · The Lancet Infectious Diseases · 2019 · 205 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers

Jaap T. van Dissel, Sandra M. Arend, Corine Prins et al. · Vaccine · 2010 · 202 citations

Life Sciences, Immunology, Microbiology +13